Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
The Importance of Networking for MSLs with Amy Misnik
Summary
Today I have Amy Misnik on the podcast. She is the Director, Medical Science Liaisons, Hematology Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson. Today she will be sharing about her role and you will be hearing our discussion about the importance of networking in the MSL industry.
Key Points
- Getting into the industry
- The MSL role
- Transition from MSL to MSL management
- Preparation for the transition
- The importance of networking in industry for MSL
- Examples of what people can do to help build their network
- Tips for networking for job search
- Outside of LinkedIn networking opportunities
- Advice to give to aspiring MSLs looking to break into their first industry position
- What qualities do you look for in MSLs?
This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery.com.
The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.
MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.
MSL industry, Hematology Oncology, MSL networking, Medical Science Liaison, pharmaceutical career
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO